Technology transforms patient feedback into data to improve cannabinoid therapy treatments and products
A new global platform promises to revolutionize the medical cannabis market by giving patients a voice and transforming their experiences into qualified scientific data (Real World Evidence - RWE). The initiative, developed by Joseph C. Chen, who was part of the team of technologists originally from Blackberry®, seeks to integrate science and practice to boost the effectiveness of endocannabinoid medicine treatments in Brazil, Latin America and the world.
Listening to the patient to transform science
The project aims to put the patient at the center of the medical cannabis ecosystem. "Medical cannabis is gaining acceptance around the world, but patient feedback is limited. Doctors lack evidence-based guidance, patients lack reliable information and the industry needs validation of results. We are giving the patient a voice and translating their experiences into information that drives the evolution of medical cannabis," explains Tiago Zamponi, General Manager Latam.
Based on patient feedback, the technology generates detailed data on the effectiveness of formulations and strains in specific conditions, such as chronic pain, insomnia, anxiety, and others. This information is made available exclusively to prescribing physicians and companies, serving as a basis for more assertive decisions. "The goal is always to suggest the best formulation for the treatment indicated for the patient, with the aim of offering the best possible effectiveness," emphasizes Zamponi.
A practical example demonstrates how the platform works: imagine 100 patients with chronic pain using a specific formulation. The data collected indicates that the effectiveness was 60%, while other patients reported additional effects, such as improved sleep. "The platform does not issue prescriptions, but works to provide physicians and companies with all the necessary information so that they can safely prescribe and develop the best formulation, always aiming for the benefit of the patient," emphasizes Zamponi.
Qualified data to improve products and treatments
With subscriptions ranging from levels A, B, and C, the platform offers access to data that helps both physicians and companies in the search for better therapeutic solutions. The Company already operates in countries such as Canada, New Zealand, the United States, Australia and Israel.
Science as the foundation of medicinal cannabis
"Cannabis without a scientific basis is just a commodity. When combined with science, it reveals its full therapeutic potential", highlights Zamponi. The platform reinforces the importance of qualified data, which not only helps to improve treatments, but also raises the standard of product development in the sector.
Interactive library and intelligence for prescriptions
The platform includes a library with more than 10 years of studies on different formulations, products and strains, offering doctors and companies a starting point to prescribe and develop products with greater safety. With practical examples, such as the effectiveness of formulations in patients with specific pains, it aims to facilitate evidence-based decisions.
Impact on the medicinal cannabis ecosystem
The initiative is a bridge between the needs of patients and scientific advances, providing information that benefits all players in the sector. "This connection transforms the patient´s experience into a valuable input for science, improving products and treatments and, ultimately, the patient´s quality of life. In this way, we circulate information to everyone involved in this ecosystem (producers, companies, doctors and patients). Before, information only went in one direction (from the seed to the patient) and now we are making the information return from the patient to the seed, closing the cycle of medicinal cannabis", concludes Zamponi.
Source: https://sechat.com.br/noticia/plataforma-conecta-experiencia-do-paciente-com-avancos-cientificos-na-cannabis-medicinal-1
Platform connects patient experience with scientific advances in medicinal cannabis
